Risk Factors for Acute Exacerbation of Chronic Obstructive Pulmonary Disease in Industrial Regions of China: A Multicenter Cross-Sectional Study

References

• RabeKF, HurdS, AnzuetoA, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007;176(6):532–555. doi:10.1164/rccm.200703-456SO17507545
   PubMed Web of Science ®Google Scholar
• VestboJ, HurdSS, AgustíAG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187(4):347–365. doi:10.1164/rccm.201204-0596PP22878278
   PubMed Web of Science ®Google Scholar
• LopezAD, ShibuyaK, RaoC, et al. Chronic obstructive pulmonary disease: current burden and future projections. Eur Respir J. 2006;27(2):397–412. doi:10.1183/09031936.06.0002580516452599
   PubMed Web of Science ®Google Scholar
• GodtfredsenNS, LamTH, HanselTT, et al. COPD-related morbidity and mortality after smoking cessation: status of the evidence. Eur Respir J. 2008;32(4):844–853. doi:10.1183/09031936.0016000718827152
   PubMed Web of Science ®Google Scholar
• DonaldsonGC, SeemungalTAR, BhowmikA, WedzichaJA. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax. 2002;57(10):847–852. doi:10.1136/thorax.57.10.84712324669
   PubMed Web of Science ®Google Scholar
• MiravitllesM, FerrerM, PontA, et al. Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study. Thorax. 2004;59(5):387–395. doi:10.1136/thx.2003.00873015115864
   PubMed Web of Science ®Google Scholar
• HawkinsPE, AlamJ, McDonnellTJ, KellyE. Defining exacerbations in chronic obstructive pulmonary disease. Expert Rev Respir Med. 2015;9(3):277–286. doi:10.1586/17476348.2015.104643826013261
   PubMed Web of Science ®Google Scholar
• EstebanC, QuintanaJM, MorazaJ, et al. Impact of hospitalisations for exacerbations of COPD on health-related quality of life. Respir Med. 2009;103(8):1201–1208. doi:10.1016/j.rmed.2009.02.00219272762
   PubMed Web of Science ®Google Scholar
• BuistAS, McBurnieMA, VollmerWM, et al. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet (London, England). 2007;370(9589):741–750. doi:10.1016/S0140-6736(07)61377-4
   PubMed Web of Science ®Google Scholar
• AgustiA, CalverleyPMA, CelliB, et al. Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res. 2010;11:122. doi:10.1186/1465-9921-11-12220831787
   PubMed Web of Science ®Google Scholar
• VarmaghaniM, DehghaniM, HeidariE, SharifiF, MoghaddamSS, FarzadfarF. Global prevalence of chronic obstructive pulmonary disease: systematic review and meta-analysis. East Mediterr Health J. 2019;25(1):47–57. doi:10.26719/emhj.18.01430919925
   PubMed Web of Science ®Google Scholar
• HalbertRJ, NatoliJL, GanoA, BadamgaravE, BuistAS, ManninoDM. Global burden of COPD: systematic review and meta-analysis. Eur Respir J. 2006;28(3):523–532. doi:10.1183/09031936.06.0012460516611654
   PubMed Web of Science ®Google Scholar
• JanssensW, BouillonR, ClaesB, et al. Vitamin D deficiency is highly prevalent in COPD and correlates with variants in the vitamin D-binding gene. Thorax. 2010;65(3):215–220. doi:10.1136/thx.2009.12065919996341
   PubMed Web of Science ®Google Scholar
• HerrC, GreulichT, KoczullaRA, et al. The role of vitamin D in pulmonary disease: COPD, asthma, infection, and cancer. Respir Res. 2011;12:31. doi:10.1186/1465-9921-12-3121418564
   PubMed Web of Science ®Google Scholar
• KaratekinG, KayaA, SalihoğluO, BalciH, NuhoğluA. Association of subclinical vitamin D deficiency in newborns with acute lower respiratory infection and their mothers. Eur J Clin Nutr. 2009;63(4):473–477. doi:10.1038/sj.ejcn.160296018030309
   PubMed Web of Science ®Google Scholar
• QuraishiSA, BittnerEA, ChristopherKB, CamargoCA, SalluhJ. Vitamin D status and community-acquired pneumonia: results from the third National Health and Nutrition Examination Survey. PLoS One. 2013;8(11):e81120. doi:10.1371/journal.pone.008112024260547
   PubMed Web of Science ®Google Scholar
• JonesPW, HardingG, BerryP, WiklundI, ChenWH, Kline LeidyN. Development and first validation of the COPD assessment test. Eur Respir J. 2009;34(3):648–654. doi:10.1183/09031936.0010250919720809
   PubMed Web of Science ®Google Scholar
• VogelmeierCF, CrinerGJ, MartinezFJ, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary. Am J Respir Crit Care Med. 2017;195(5):557–582. doi:10.1164/rccm.201701-0218PP28128970
   PubMed Web of Science ®Google Scholar
• Folch AyoraA, Macia-SolerL, Orts-CortésMI, HernándezC, Seijas-BabotN. Comparative analysis of the psychometric parameters of two quality-of-life questionnaires, the SGRQ and CAT, in the assessment of patients with COPD exacerbations during hospitalization: a multicenter study. Chron Respir Dis. 2018;15(4):374–383. doi:10.1177/147997231876164529529879
   PubMed Web of Science ®Google Scholar
• TuY-H, ZhangY, FeiG-H. Utility of the CAT in the therapy assessment of COPD exacerbations in China. BMC Pulm Med. 2014;14:42. doi:10.1186/1471-2466-14-4224618290
   PubMed Web of Science ®Google Scholar
• Soler-CataluñaJJ, Martínez-GarcíaMA, Román SánchezP, SalcedoE, NavarroM, OchandoR. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax. 2005;60(11):925–931. doi:10.1136/thx.2005.04052716055622
   PubMed Web of Science ®Google Scholar
• HalpinDM, MiravitllesM, MetzdorfN, CelliB. Impact and prevention of severe exacerbations of COPD: a review of the evidence. Int J Chron Obstruct Pulmon Dis. 2017;12:2891–2908. doi:10.2147/COPD.S13947029062228
   PubMed Web of Science ®Google Scholar
• López-CamposJL, TanW, SorianoJB. Global burden of COPD. Respirology (Carlton, Vic). 2016;21(1):14–23. doi:10.1111/resp.12660
   PubMed Web of Science ®Google Scholar
• Van RemoortelH, HornikxM, LangerD, et al. Risk factors and comorbidities in the preclinical stages of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2014;189(1):30–38.24219412
   PubMed Web of Science ®Google Scholar
• SiafakasNM, VermeireP, PrideNB, et al. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. Eur Respir J. 1995;8(8):1398–1420. doi:10.1183/09031936.95.080813987489808
   PubMed Web of Science ®Google Scholar
• The COPD Guidelines Group of the Standards of Care Committee of the BTS. BTS guidelines for the management of chronic obstructive pulmonary disease. Thorax. 1997;52(Suppl 5):S1–28. doi:10.1136/thx.52.suppl_5.1
   PubMed Web of Science ®Google Scholar
• KerstjensHA, RijckenB, SchoutenJP, PostmaDS. Decline of FEV1 by age and smoking status: facts, figures, and fallacies. Thorax. 1997;52(9):820–827. doi:10.1136/thx.52.9.8209371217
   PubMed Web of Science ®Google Scholar
• Montserrat-CapdevilaJ, GodoyP, MarsalJR, BarbéF, GalvánL. Risk of exacerbation in chronic obstructive pulmonary disease: a primary care retrospective cohort study. BMC Fam Pract. 2015;16:173. doi:10.1186/s12875-015-0387-626642879
   PubMed Web of Science ®Google Scholar
• MercadoN, ItoK, BarnesPJ. Accelerated ageing of the lung in COPD: new concepts. Thorax. 2015;70(5):482–489. doi:10.1136/thoraxjnl-2014-20608425739910
   PubMed Web of Science ®Google Scholar
• SmithMC, WrobelJP. Epidemiology and clinical impact of major comorbidities in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2014;9:871–888. doi:10.2147/COPD.S4962125210449
   PubMed Web of Science ®Google Scholar
• DenizS, ŞengülA, AydemirY, Çeldir EmreJ, ÖzhanMH. Clinical factors and comorbidities affecting the cost of hospital-treated COPD. Int J Chron Obstruct Pulmon Dis. 2016;11:3023–3030. doi:10.2147/COPD.S12063727980399
   PubMed Web of Science ®Google Scholar
• YangH, WangH, DuL, WangY, WangX, ZhangR. Disease knowledge and self-management behavior of COPD patients in China. Medicine. 2019;98(8):e14460. doi:10.1097/MD.000000000001446030813148
   PubMed Web of Science ®Google Scholar
• GeorgeJ, KongDCM, StewartK. Adherence to disease management programs in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2007;2(3):253–262.18229563
   PubMedGoogle Scholar
• BourbeauJ, BartlettSJ. Patient adherence in COPD. Thorax. 2008;63(9):831–838. doi:10.1136/thx.2007.08604118728206
   PubMed Web of Science ®Google Scholar
• VetranoDL, BianchiniE, OnderG, et al. Poor adherence to chronic obstructive pulmonary disease medications in primary care: role of age, disease burden and polypharmacy. Geriatr Gerontol Int. 2017;17(12):2500–2506. doi:10.1111/ggi.1311528656664
   PubMed Web of Science ®Google Scholar
• Duarte-de-AraújoA, TeixeiraP, HespanholV, Correia-de-SousaJ. COPD: understanding patients’ adherence to inhaled medications. Int J Chron Obstruct Pulmon Dis. 2018;13:2767–2773. doi:10.2147/COPD.S16098230233167
   PubMed Web of Science ®Google Scholar
• VestboJ, AndersonJA, CalverleyPMA, et al. Adherence to inhaled therapy, mortality and hospital admission in COPD. Thorax. 2009;64(11):939–943. doi:10.1136/thx.2009.11366219703830
   PubMed Web of Science ®Google Scholar
• van BovenJFM, ChavannesNH, van der MolenT, Rutten-van MölkenMPMH, PostmaMJ, VegterS. Clinical and economic impact of non-adherence in COPD: a systematic review. Respir Med. 2014;108(1):103–113. doi:10.1016/j.rmed.2013.08.04424070566
   PubMed Web of Science ®Google Scholar
• PereraPN, ArmstrongEP, SherrillDL, SkrepnekGH. Acute exacerbations of COPD in the United States: inpatient burden and predictors of costs and mortality. Copd. 2012;9(2):131–141. doi:10.3109/15412555.2011.65023922409371
   PubMedGoogle Scholar
• GerminiF, VeroneseG, MarcucciM, et al. COPD exacerbations in the emergency department: epidemiology and related costs. A retrospective cohort multicentre study from the Italian Society of Emergency Medicine (SIMEU). Eur J Intern Med. 2018;51:74–79. doi:10.1016/j.ejim.2018.01.01029371059
   PubMed Web of Science ®Google Scholar
• JenkinsCR, CelliB, AndersonJA, et al. Seasonality and determinants of moderate and severe COPD exacerbations in the TORCH study. Eur Respir J. 2012;39(1):38–45. doi:10.1183/09031936.0019461021737561
   PubMed Web of Science ®Google Scholar
• TsengC-M, ChenY-T, OuS-M, et al. The effect of cold temperature on increased exacerbation of chronic obstructive pulmonary disease: a nationwide study. PLoS One. 2013;8(3):e57066. doi:10.1371/journal.pone.005706623554858
   PubMed Web of Science ®Google Scholar
• DingP-H, WangG-S, GuoY-L, ChangS-C, WanG-H. Urban air pollution and meteorological factors affect emergency department visits of elderly patients with chronic obstructive pulmonary disease in Taiwan. Environ Pollut. 2017;224:751–758. doi:10.1016/j.envpol.2016.12.03528284553
   PubMed Web of Science ®Google Scholar
• de Miguel-díezJ, Hernández-VázquezJ, López-de-AndrésA, Álvaro-MecaA, Hernández-BarreraV, Jiménez-GarcíaR. Analysis of environmental risk factors for chronic obstructive pulmonary disease exacerbation: a case-crossover study (2004–2013). PLoS One. 2019;14(5):e0217143. doi:10.1371/journal.pone.021714331120946
   PubMed Web of Science ®Google Scholar